CADTH Releases Its Annual List of Health Technology Trends to Watch

JAMP Pharma Group, the Québec leader in prescription volume, launches Guanfacine XR, a niche generic that is equivalent to the reference product in size and appearance, offering an affordable alternative.

NewsCatherine LamontagneMarch 29, 2022JAMP Pharma Group, ADHD

JAMP Pharma Group launches a new generic drug for the treatment of attention deficit hyperactivity disorder (ADHD)

JAMP Pharma Group, the Québec leader in prescription volume, launches Guanfacine XR, a niche generic that is equivalent to the reference product in size and appearance, offering an affordable alternative.

NewsCatherine LamontagneFebruary 21, 2022JAMP Pharma Group, ADHD

Canadian JAMP Pharma Group Gets Involved - Donating one million doses of hydroxychloroquine to hospitals to help combat COVID-19

JAMP Pharma Group, a Canadian pharmaceutical company, announced today that it is donating one million doses of hydroxychloroquine to Canadian hospitals, a drug that is normally used to treat malaria and rheumatoid arthritis and which could potentially be useful in treating hospitalized patients infected with the COVID-19 virus.